Oracle
ORCL
Netflix
NFLX
Meta Platforms
META
4
Apple
AAPL
5
Tesla
TSLA
US Stock MarketDetailed Quotes
BMY Bristol-Myers Squibb
- 48.460
- +0.560+1.17%
Close Apr 28 16:00 ET
- 48.450
- -0.010-0.02%
Post 18:16 ET
98.62BMarket Cap18.08P/E (TTM)
48.860High47.920Low18.57MVolume48.310Open47.900Pre Close897.39MTurnover0.91%Turnover RatioLossP/E (Static)2.04BShares62.65152wk High5.67P/B98.43BFloat Cap37.77352wk Low2.44Dividend TTM2.03BShs Float73.237Historical High5.04%Div YieldTTM1.96%Amplitude8.115Historical Low48.316Avg Price1Lot Size
About Bristol-Myers Squibb Company
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Company Profile
SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher S. Boerner, PhD
- Chairman of the Board and Chief Executive Officer
- 18.79M
- Amanda Ahn Poole
- Executive Vice President and Chief People Officer
- --
- Gregory Scott Meyers
- Executive Vice President, Chief Digital Officer and Chief Technology Officer
- --
- David V. Elkins
- Executive Vice President and Chief Financial Officer
- 8.71M
- Adam Lenkowsky
- Executive Vice President and Chief Commercialization Officer
- --
- Dr. Samit Hirawat, M.D.
- Executive Vice President, Chief Medical Officer and Head of Development
- 8.59M
- Dr. Robert M. Plenge, M.D.,PhD
- Executive Vice President, Chief Research Officer and Head of Research
- --
- Phil Holzer
- Senior Vice President, Principal Accounting Officer and Controller
- --
- Karin Shanahan
- Executive Vice President, Global Product Development and Supply
- 6.57M
- Cari Gallman
- Executive Vice President, Corporate Affairs
- --
- Sandra Leung
- Executive Vice President and General Counsel
- 7.01M
- Lynelle Hoch
- President, Cell Therapy Organization
- --
- Benjamin J. Hickey, M.B.A.
- President, RayzeBio Organization
- --
- Phyllis R. Yale
- Independent Director
- 380.00K
- Paula A. Price
- Independent Director
- 380.00K
- Theodore R. Samuels
- Lead Independent Director
- 440.00K
- Peter J. Arduini
- Independent Director
- 376.79K
- Michael R. McMullen
- Independent Director
- 185.86K
- Derica W. Rice
- Independent Director
- 390.00K
- Dr. Manuel Hidalgo Medina, M.D.,PhD
- Independent Director
- 350.00K
- Dr. Karen H. Vousden, PhD
- Independent Director
- 350.00K
- Dr. Julia A. Haller, M.D.
- Independent Director
- 390.00K
- Dr. Deepak L. Bhatt, M.D.,M.P.H.
- Independent Director
- 350.00K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀